Compare INUV & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INUV | CCEL |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.3M | 32.7M |
| IPO Year | 1996 | 2022 |
| Metric | INUV | CCEL |
|---|---|---|
| Price | $1.86 | $3.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 217.9K | 14.2K |
| Earning Date | 05-08-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 4.17% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $86,209,305.00 | $25,384,279.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.65 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 2.88 | ★ 9.76 |
| 52 Week Low | $0.34 | $2.72 |
| 52 Week High | $6.27 | $6.03 |
| Indicator | INUV | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 39.01 | 61.72 |
| Support Level | $1.83 | $3.18 |
| Resistance Level | $1.99 | $4.32 |
| Average True Range (ATR) | 0.16 | 0.25 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 13.73 | 79.84 |
Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.